Cardiovascular Care Settings and Smoking Cessation

Smoking Causes Cardiovascular Disease

Cardiovascular disease (CVD) is the leading cause of death in the United States. Cigarette smoking is a major cause of CVD and is responsible for about 1 in every 4 U.S. deaths from CVD.

Research shows that smoking increases risk of CVD, including:

Atherosclerosis
Coronary heart disease (CHD), including myocardial infarction and sudden cardiac death
Stroke
Peripheral arterial disease
Abdominal aortic aneurysm

People with CHD who continue to smoke cigarettes after revascularization may have adverse clinical outcomes, including stent thrombosis. Research also shows that exposure to secondhand smoke increases risk of CHD and stroke.

Smoking cessation improves cardiovascular health. Healthcare professionals, particularly those in cardiovascular care, should treat patients’ tobacco use and dependence.

Smoking and Cardiovascular Disease – What Healthcare Professionals Need to Know

[PDF - 255 KB]

Smoking Causes Cardiovascular Disease

Cardiovascular disease (CVD) is the leading cause of death in the United States. Cigarette smoking is a major cause of CVD and is responsible for about 1 in every 4 U.S. deaths from CVD.

Research shows that smoking increases risk of CVD, including:

Atherosclerosis
Coronary heart disease (CHD), including myocardial infarction and sudden cardiac death
Stroke
Peripheral arterial disease
Abdominal aortic aneurysm

Smoking and Cardiovascular Disease – What Healthcare Professionals Need to Know

[PDF]

Smoking Cessation Improves Heart Health

Smoking cessation is one of the most important actions people who smoke can take to reduce their risk for CVD. This is true for all people who smoke, regardless of age or smoking duration and intensity. The health benefits also extend to patients already diagnosed with CHD.

The cardiovascular benefits of smoking cessation include:

Reduces markers of inflammation and hypercoagulability
Leads to rapid improvement in high-density lipoprotein cholesterol (HDL-C) levels.
Reduces the development of subclinical atherosclerosis and slows progression as time since cessation lengthens.
Reduces the risk of disease and death from CVD.
Reduces the risk of coronary heart disease, with risk falling sharply 1 to 2 years after cessation and then declining more slowly over the longer term.
Reduces the risk of disease and death from stroke, with risk approaching that of never smokers after cessation.
Reduces the risk of abdominal aortic aneurysm, with risk reduction increasing with time since cessation.
May reduce the risk of atrial fibrillation, sudden cardiac death, heart failure, venous thromboembolism, and peripheral arterial disease.